Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SASR
6826
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.04M | ﹤0.01% |
+26,589
| New | +$1.09M |
|
6827
CALL
iShares Russell Mid-Cap Growth ETF
IWP
$20.8B
| $1.04M | ﹤0.01% |
13,100
-9,600
| -42% | -$836K |
|
6828
iShares New York Muni Bond ETF
NYF
$1.43B
| $1.04M | ﹤0.01% |
+19,740
| New | +$1.04M |
|
6829
PUT
Impinj
PI
$5.13B
| $1.04M | ﹤0.01% |
17,700
-19,100
| -52% | -$959K |
|
6830
SunCoke Energy
SXC
$775M
| $1.04M | ﹤0.01% |
152,159
+19,065
| +14% | +$154K |
|
6831
PUT
BWX Technologies
BWXT
$15.2B
| $1.04M | ﹤0.01% |
18,800
-4,600
| -20% | -$239K |
|
6832
CALL
Euronet Worldwide
EEFT
$2.61B
| $1.04M | ﹤0.01% |
10,300
-16,100
| -61% | -$1.91M |
|
6833
Hope Bancorp
HOPE
$1.82B
| $1.04M | ﹤0.01% |
74,827
-6,436
| -8% | -$94K |
|
6834
Innovator Growth-100 Power Buffer ETF July
NJUL
$265M
| $1.04M | ﹤0.01% |
+24,108
| New | +$1.07M |
|
|
TCRR
6835
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.04M | ﹤0.01% |
357,222
+39,438
| +12% | +$97.3K |
|
|
IMPX
6836
CALL
DELISTED
AEA-Bridges Impact Corp
IMPX
| $1.04M | ﹤0.01% |
104,400
-10,700
| -9% | -$106K |
|
6837
iShares Core S&P Total US Stock Market ETF
ITOT
$97.2B
| $1.03M | ﹤0.01% |
12,357
+8,202
| +197% | +$747K |
|
|
SWCH
6838
PUT
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.03M | ﹤0.01% |
30,900
-83,000
| -73% | -$2.68M |
|
6839
PUT
Clover Health Investments
CLOV
$2.26B
| $1.03M | ﹤0.01% |
483,400
-1,168,300
| -71% | -$3.1M |
|
6840
Franklin FTSE Brazil ETF
FLBR
$523M
| $1.03M | ﹤0.01% |
61,980
+39,320
| +174% | +$811K |
|
6841
CALL
Vanguard Morningstar Large-Cap ETF
VV
$54.2B
| $1.03M | ﹤0.01% |
6,000
+1,500
| +33% | +$282K |
|
|
TE
6842
PUT
T1 Energy
TE
$1.36B
| $1.03M | ﹤0.01% |
151,100
-65,400
| -30% | -$573K |
|
|
ATSG
6843
DELISTED
Air Transport Services Group
ATSG
| $1.03M | ﹤0.01% |
36,003
-12,717
| -26% | -$387K |
|
|
JAMF
6844
CALL
DELISTED
Jamf
JAMF
| $1.03M | ﹤0.01% |
41,700
-202,700
| -83% | -$5.68M |
|
6845
CALL
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.42B
| $1.03M | ﹤0.01% |
16,400
+9,500
| +138% | +$650K |
|
6846
CALL
Cheniere Energy
CQP
$33.2B
| $1.03M | ﹤0.01% |
23,000
-25,800
| -53% | -$1.36M |
|
6847
PUT
Commault Systems
CVLT
$6B
| $1.03M | ﹤0.01% |
16,400
-8,000
| -33% | -$497K |
|
6848
PUT
Agree Realty
ADC
$9.23B
| $1.03M | ﹤0.01% |
14,300
-15,300
| -52% | -$1.06M |
|
|
DAWN
6849
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.03M | ﹤0.01% |
+57,600
| New | +$595K |
|
6850
PUT
Essent Group
ESNT
$6.24B
| $1.03M | ﹤0.01% |
26,500
+4,300
| +19% | +$175K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.